Please Wait.....
Report
Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets
Market Research Report I 2024-12-17 I 130 Pages I BCC Research
Description
Report Scope
The global laboratory animal models, 3D cultures, and organoids market is identified and explored in this report, as are all significant global companies active in the market. Markets are broken out globally and by geographic region. Additionally, all major animal models and applications are covered in detail. The current report will provide detailed exposure about this market.
This report analyzes market trends using data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period 2024-2029), and regional markets. This report will highlight current and future market potential and give a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2029 and the market shares of key players.
This report details market shares for the different segments, their types and applications, end users, and geography. Based on animal models, the market is segmented into gelatin and vegetarian capsules. The market is segmented based on its nutritional, pharmaceutical, and cosmeceutical applications. Based on end users, the market is segmented into pharmaceutical and nutraceutical companies, contract manufacturing companies, and others.
The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, and other world regions. The regional segment includes a detailed analysis of major countries such as the U.S., Germany, the U.K., France, Japan, China, and India.
The report's goals include:
- Analyzing product types and applications.
- Analyzing global market size and segmentation.
- Understanding market constraints and drivers.
- Providing detailed market forecasts up to 2029.
- Assessing market shares, competitiveness, and industry structure.
- Identifying potential long-term impacts on the market.
Report Includes
- 45 data tables and 52 additional tables
- An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry
- Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
- Estimation of the actual market size and market forecast for organoids, and their corresponding market share analysis by product type, application, and geographic region
- Coverage of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market
- Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and for evaluating the safety and metabolism of chemical compounds
- Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry
- Review of selected patents and patent applications on organoids, and emerging developments in the global market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Assessment of mergers and acquisitions, joint ventures, partnerships, and other market strategies
- A discussion of ESG challenges and practices in the industry
- Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Corning Inc., genOway, Charles River Laboratories, and Bio-Techne.
Executive Summary
Summary:
The established laboratory animal model industry is currently facing a paradigm shift due to the emergence and adoption of 3D cell culture systems. This shift is primarily driven by the growing demand for personalized healthcare and the need for faster, more reliable, and cost-effective drug screening. Advances in stem cell biology have enabled the creation of diverse cell and tissue types in vitro, offering promising alternatives to traditional animal models.
While animal models remain indispensable for general drug screening and safety testing, there is a growing recognition of their limitations in providing a personalized approach to patients. The increasing focus on translational research and the need for safety validation of new compounds continue to drive the use of animal models. The industry is actively developing more sophisticated animal models that closely mimic human physiology to address these needs. Precise genetic editing and humanization technologies are playing a crucial role in this evolution, leading to a steady increase in the use of genetically modified animals.
The 3Rs principle (Replacement, Reduction, and Refinement) has significantly influenced the use of animals in research, promoting ethical practices and driving a shift towards more reliable and efficient experimental models. This has led to a preference for inbred strains over outbred animals, reducing the number of animals required for experiments.
As the industry continues to evolve, emerging technologies are poised to complement and sometimes replace animal models. 3D cell cultures are gaining traction in areas where animal models are cost-prohibitive or unsuitable for specific research questions. Observing and analyzing experiments in real-time is a crucial advantage of 3D cell cultures, making them particularly valuable for studying individual patient conditions and preclinical research.
In basic research, the simplicity, scalability, and high relevance to human physiology of 3D cell culture systems make them attractive alternatives to traditional animal models. These technologies offer the potential to generate more data in highly controlled settings, accelerating scientific discovery.
The laboratory animal models, 3D cultures and organoids market are influenced by 3D cell cultures, especially organoids. The market is expected to continue growing due to the growing focus on ethical alternatives to animal testing, increasing demand for tumor modeling and biobanking fuels market expansion, and rising adoption of organoid technology for broader applications, which are driving the market size for the forecast period. Manufacturers must prioritize sustainability, innovation, and quality to remain competitive and meet evolving consumer demands.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Overview
Market Drivers
Growing Focus on Ethical Alternatives to Animal Testing
Increasing Demand for Tumor Modeling and Biobanking Fuel Market Expansion
Increasing Adoption of Organoid Technology for Wider Applications
Market Restraints
Strict Government Regulations Governing Cell Cultures and Stem Cells R&D
Challenges in Incorporating Organoids into Existing Research Practices
Market Opportunities
Applications in Drug Development, Personalized Medicine, and Transplantation
Chapter 4 Regulatory Landscape
Regulatory Scenarios
United States
EU
U.K.
Germany
India
Chapter 5 Emerging Technologies
Overview
3D Printing
Microfluidics
Artificial Intelligence and Automation
Patent Analysis
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Animal Model
Animal Models
Global Market Size and Forecast
Mice
Rats
Rabbits
Hamsters
Guinea Pigs
Others
Global Market for Laboratory Animal Models, 3D Cultures and Organoid, by 3D Cultures
3D Cultures
Global Market Size and Forecast
Organ-on-chip
Organoids
Intestine
Liver
Stomach
Pancreas
Lung
Kidney
Others
Spheroids
Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Application
Developmental Biology
Drug Discovery and Personalized Medicine
Regenerative Medicine
Pathology of Infectious Disease
Drug Toxicity and Efficacy Testing
Others
Geographic Breakdown
Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Region
Global Market Size and Forecast
North America
U.S.
Canada
Market Size and Forecast
Europe
Germany
U.K.
Market Size and Forecast
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Competitive Landscape
Strategic Analysis
Chapter 8 Sustainability in Laboratory Animal Models, 3D Cultures, and Organoids: An ESG Perspective
Introduction to ESG
Sustainability in the Market
ESG Perspective
Environmental Impact
Social Impact
Governance
Chapter 9 Appendix
Methodology
Abbreviations
Sources
Company Profiles
3D BIOTEK LLC.
BIO-TECHNE
CELLINK
CHARLES RIVER LABORATORIES
CHERRY BIOTECH
CORNING INC.
EMULATE
GENOWAY
GREINER BIO-ONE INTERNATIONAL GMBH
INSPHERO
MATTEK
MIMETAS B.V.
PEPGEL LLC.
POIETIS
TACONIC BIOSCIENCES INC.
THEWELL BIOSCIENCE INC.
THERMO FISHER SCIENTIFIC INC.
List of Tables
Summary Table : Global Market for Laboratory Animal Models, 3D Cultures, and Organoids, by Segment, Through 2029
Table 1 : Animal Model vs. 3D Cell Culture
Table 2 : Porter's Five Forces Analysis: Laboratory Animal Models, 3D Cultures, and Organoids
Table 3 : Patent Analysis for 3D Cell Culture
Table 4 : Global Market for Animal Models, by Animal Type, Through 2029
Table 5 : Global Market for Mice Animal Models, by Region, Through 2029
Table 6 : Global Market for Rat Animal Models, by Region, Through 2029
Table 7 : Global Market for Rabbit Animal Models, by Region, Through 2029
Table 8 : Global Market for Hamster Animal Models, by Region, Through 2029
Table 9 : Global Market for Guinea Pig Animal Models, by Region, Through 2029
Table 10 : Global Market for Other Animal Models, by Region, Through 2029
Table 11 : Global Market for 3D Cell Cultures, by 3D Type, Through 2029
Table 12 : Global Market for Organ-on-chips in 3D Cultures, by Region, Through 2029
Table 13 : Global Market for Organoids in 3D Cultures, by Organ Type, Through 2029
Table 14 : Global Market for Organoid in 3D Cultures, by Region, Through 2029
Table 15 : Global Market for Intestines in Organoids, by Region, Through 2029
Table 16 : Global Market for Livers in Organoids, by Region, Through 2029
Table 17 : Global Market for Stomachs in Organoids, by Region, Through 2029
Table 18 : Global Market for Pancreases in Organoids, by Region, Through 2029
Table 19 : Global Market for Lungs in Organoids, by Region, Through 2029
Table 20 : Global Market for Kidneys in Organoids, by Region, Through 2029
Table 21 : Global Market for Other in Organoids, by Region, Through 2029
Table 22 : Global Market for Spheroids in 3D Cultures, by Region, Through 2029
Table 23 : Global Market for Laboratory Animal Models, 3D Cultures, and Organoids, by Application, Through 2029
Table 24 : Global Market for Developmental Biology in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 25 : Global Market for Drug Discovery and Personalized Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 26 : Global Market for Regenerative Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 27 : Global Market for Pathology of Infectious Diseases in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 28 : Global Market for Drug Toxicity and Efficacy Testing in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 29 : Global Market for Other Applications in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 30 : Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 31 : North American Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 32 : North American Market for 3D Cell Cultures, by Type, Through 2029
Table 33 : North American Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 34 : European Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 35 : European Market for 3D Cell Cultures, by Type, Through 2029
Table 36 : European Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 37 : Asia-Pacific Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 38 : Asia-Pacific Market for 3D Cell Cultures, by Type, Through 2029
Table 39 : Asia-Pacific Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 40 : Rest of the World Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 41 : Rest of the World Market for 3D Cell Cultures, by Type, Through 2029
Table 42 : Rest of the World Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 43 : Global Company Rankings in the Market for Laboratory Animal Models, 3D Cultures and Organoids, 2023
Table 44 : Key ESG Metrics Focus Areas
Table 45 : ESG Rankings for CRO Services, 2023
Table 46 : Abbreviations Used in this Report
Table 47 : Report Sources
Table 48 : 3D Biotek LLC.: Company Snapshot
Table 49 : 3D Biotek LLC.: Product Portfolio
Table 50 : Bio-Techne: Company Snapshot
Table 51 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 52 : Bio-Techne: Product Portfolio
Table 53 : Bio-Techne: News/Key Developments, 2022
Table 54 : Cellink: Company Snapshot
Table 55 : Cellink: Product Portfolio
Table 56 : Cellink: News/Key Developments, 2023
Table 57 : Charles River Laboratories: Company Snapshot
Table 58 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 59 : Charles River Laboratories: Products Portfolio
Table 60 : Charles River Laboratories: News/Key Developments, 2023
Table 61 : Cherry Biotech: Company Snapshot
Table 62 : Cherry Biotech: Product Portfolio
Table 63 : Corning Inc.: Company Snapshot
Table 64 : Corning Inc.: Financial Performance, FY 2022 and 2023
Table 65 : Corning Inc.: Product Portfolio
Table 66 : Corning Inc.: News/Key Developments, 2022-2024
Table 67 : Emulate: Company Snapshot
Table 68 : Emulate: Product Portfolio
Table 69 : Emulate: News/Key Developments, 2021-2023
Table 70 : genOway: Company Snapshot
Table 71 : genOway: Financial Performance, FY 2022 and 2023
Table 72 : genOway: Product Portfolio
Table 73 : genOway: News/Key Developments, 2021 and 2022
Table 74 : Greiner Bio-One International GmbH: Company Snapshot
Table 75 : Greiner Bio-One International GmbH: Product Portfolio
Table 76 : InSphero: Company Snapshot
Table 77 : InSphero: Product Portfolio
Table 78 : InSphero: News/Key Developments, 2023
Table 79 : MatTek: Company Snapshot
Table 80 : MatTek: Product Portfolio
Table 81 : Mimetas B.V.: Company Snapshot
Table 82 : Mimetas B.V.: Product Portfolio
Table 83 : Mimetas B.V.: News/Key Developments, 2023-2024
Table 84 : PepGel LLC.: Company Snapshot
Table 85 : PepGel LLC.: Product Portfolio
Table 86 : Poietis: Company Snapshot
Table 87 : Poietis: Product Portfolio
Table 88 : Poietis: News/Key Developments, 2024
Table 89 : Taconic Biosciences Inc.: Company Snapshot
Table 90 : Taconic Biosciences Inc.: Product Portfolio
Table 91 : TheWell Bioscience Inc.: Company Snapshot
Table 92 : TheWell Bioscience Inc.: Product Portfolio
Table 93 : TheWell Bioscience Inc.: News/Key Developments, 2023-2024
Table 94 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 95 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 96 : Thermo Fisher Scientific Inc.: Product Portfolio
List of Figures
Summary Figure : Global Market Shares of Laboratory Animal Models, 3D Cultures, and Organoids, by Segment, 2021-2029
Figure 1 : Animal Modelling for Drug Discovery
Figure 2 : Evolution of 3D Cell Culture
Figure 3 : Market Dynamics of Laboratory Animal Models, 3D Cultures, and Organoids
Figure 4 : Global Market Shares of Animal Models, by Animal Type, 2023
Figure 5 : Global Market Shares of Mice Animal Models, by Region, 2023
Figure 6 : Global Market Shares of Rat Animal Models, by Region, 2023
Figure 7 : Global Market Shares of Rabbit Animal Models, by Region, 2023
Figure 8 : Global Market Shares of Hamster Animal Models, by Region, 2023
Figure 9 : Global Market Shares of Guinea Pig Animal Models, by Region, 2023
Figure 10 : Global Market Shares of Other Animal Models, by Region, 2023
Figure 11 : Types of 3D Cell Culture Utilized in Drug Discovery
Figure 12 : Global Market Shares of 3D Cell Cultures, by 3D Type, 2023
Figure 13 : Global Market Shares of Organ-on-chips in 3D Cultures, by Region, 2023
Figure 14 : Global Market Shares of Organoids in 3D Cultures, by Organ Type, 2023
Figure 15 : Global Market Shares of Organoid in 3D Cultures, by Region, 2023
Figure 16 : Global Market Shares of Intestines in Organoids, by Region, 2023
Figure 17 : Global Market Shares of Livers in Organoids, by Region, 2023
Figure 18 : Global Market Shares of Livers in Organoids, by Region, 2023
Figure 19 : Global Market Shares of Pancreases in Organoids, by Region, 2023
Figure 20 : Global Market Shares of Lungs in Organoids, by Region, 2023
Figure 21 : Global Market Shares of Kidneys in Organoids, by Region, 2023
Figure 22 : Global Market Shares of Other in Organoids, by Region, 2023
Figure 23 : Global Market Shares of Spheroids in 3D Cultures, by Region, 2023
Figure 24 : Global Market Shares of Laboratory Animal Models, 3D Cultures, and Organoids, by Application, 2023
Figure 25 : Global Market Shares of Developmental Biology in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 26 : Global Market Shares of Drug Discovery and Personalized Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 27 : Global Market Shares of Regenerative Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 28 : Global Market Shares of Pathology of Infectious Diseases in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 29 : Global Market Shares of Drug Toxicity and Efficacy Testing in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 30 : Global Market Shares of Other Applications in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 31 : Global Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 32 : North American Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
Figure 33 : North American Market Shares of 3D Cell Cultures, by Type, 2023
Figure 34 : North American Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
Figure 35 : European Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segmen, 2023
Figure 36 : European Market Shares of 3D Cell Cultures, by Type, 2023
Figure 37 : European Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
Figure 38 : Asia-Pacific Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
Figure 39 : Asia-Pacific Market Shares of 3D Cell Cultures, by Type, 2023
Figure 40 : Asia-Pacific Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
Figure 41 : Rest of the World Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
Figure 42 : Rest of the World Market Shares of 3D Cell Cultures, by Type, 2023
Figure 43 : Rest of the World Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 44 : Pillars of ESG
Figure 45 : Advantages of ESG for Companies
Figure 46 : Bio-Techne: Revenue Shares, by Segment, 2023
Figure 47 : Bio-Techne: Revenue Shares, by Country/Region, 2023
Figure 48 : Charles River Laboratories: Revenue Shares, by Business Unit, FY 2023
Figure 49 : Charles River Laboratories: Revenue Shares, by Country/Region, FY 2023
Figure 50 : Corning Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 51 : Corning Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 52 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 53 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security